Literature DB >> 14981597

ARF in children with minimal change nephrotic syndrome may be related to functional changes of the glomerular basal membrane.

Johan Vande Walle1, Reiner Mauel, Ann Raes, Kristof Vandekerckhove, Raymond Donckerwolcke.   

Abstract

BACKGROUND: Acute renal failure (ARF) is a rare complication in children with minimal change nephrotic syndrome (MCNS). Several etiologic factors (renal vein thrombosis, side effect of such drugs as nonsteroidal anti-inflammatory drugs, and infections) have been described, but often such conditions are lacking, and hemodynamic derangements or changes in glomerular permeability are suspected.
METHODS: We assessed the role of alterations in renal perfusion and glomerular permeability by measuring clearances of inulin and para-aminohippurate before and during intravenous administration of a 20% albumin solution in patients with MCNS and oliguric ARF (serum creatinine > 1 mg/dL [88 micromol/L], urine output < 0.5 mL/kg body weight/h).
RESULTS: Eleven patients aged 2.5 to 15 years with biopsy-proven MCNS were studied. Before albumin administration, all patients had a significantly decreased glomerular filtration rate (GFR), whereas most renal plasma flow (RPF) values were within the normal range. This resulted in a significantly decreased filtration fraction (FF; GFR/RPF x 100), which was extremely low (<7%) in 4 patients. There was a heterogeneous response to albumin administration. Albumin infusion tended to increase RPF, but changes did not reach statistical significance. Some patients showed an increase in glomerular filtration, whereas in others, it decreased. In 7 patients, FF remained unchanged or decreased even further.
CONCLUSION: Our data suggest that, although in some patients decreased intravascular volume may contribute to reduced renal function, changes in glomerular permeability may have a major role in ARF occurring in uncomplicated MCNS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14981597     DOI: 10.1053/j.ajkd.2003.10.039

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

1.  Single low-dose rituximab for the treatment of steroid-resistant nephrotic syndrome with acute kidney injury.

Authors:  Eijin Ashikaga; Susumu Uda; Kazuhisa Kamata; Yasuto Shikida; Takashi Inoue; Yoshihiro Kuno; Atsushi Yao; Mari Nakamura; Keiko Kai
Journal:  CEN Case Rep       Date:  2016-03-25

2.  Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome.

Authors:  Rajmohan Dharmaraj; Pankaj Hari; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2009-01-14       Impact factor: 3.714

3.  Urinary potassium to urinary potassium plus sodium ratio can accurately identify hypovolemia in nephrotic syndrome: a provisional study.

Authors:  Werner Keenswijk; Mohamad Ikram Ilias; Ann Raes; Raymond Donckerwolcke; Johan Vande Walle
Journal:  Eur J Pediatr       Date:  2017-10-11       Impact factor: 3.183

Review 4.  Human albumin infusion for treating oedema in people with nephrotic syndrome.

Authors:  Jacqueline J Ho; Azreen S Adnan; Yee Cheng Kueh; Nurul Jannah Ambak; Hans Van Rostenberghe; Fauziah Jummaat
Journal:  Cochrane Database Syst Rev       Date:  2019-07-12

5.  Unique proximal tubular cell injury and the development of acute kidney injury in adult patients with minimal change nephrotic syndrome.

Authors:  Yoshihide Fujigaki; Yoshifuru Tamura; Michito Nagura; Shigeyuki Arai; Tatsuru Ota; Shigeru Shibata; Fukuo Kondo; Yutaka Yamaguchi; Shunya Uchida
Journal:  BMC Nephrol       Date:  2017-11-28       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.